Mansour Alwjwaj
The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke
Alwjwaj, Mansour; Kadir, Rais Reskiawan A; Bayraktutan, Ulvi
Authors
Abstract
Ischemic stroke continues to be a leading cause of mortality and morbidity in the world. Despite recent advances in the field of stroke medicine, thrombolysis with recombinant tissue plasminogen activator remains as the only pharmacological therapy for stroke patients. However, due to short therapeutic window (4.5 hours of stroke onset) and increased risk of hemorrhage beyond this point, each year globally less than 1% of stroke patients receive this therapy which necessitate the discovery of safe and efficacious therapeutics that can be used beyond the acute phase of stroke. Accumulating evidence indicates that endothelial progenitor cells (EPCs), equipped with an inherent capacity to migrate, proliferate and differentiate, may be one such therapeutics. However, the limited availability of EPCs in peripheral blood and early senescence of few isolated cells in culture conditions adversely affect their application as effective therapeutics. Given that much of the EPC-mediated reparative effects on neurovasculature is realized by a wide range of biologically active substances released by these cells, it is possible that EPC-secretome may serve as an important therapeutic after an ischemic stroke. In light of this assumption, this review paper firstly discusses the main constituents of EPC-secretome that may exert the beneficial effects of EPCs on neurovasculature, and then reviews the currently scant literature that focuses on its therapeutic capacity.
Citation
Alwjwaj, M., Kadir, R. R. A., & Bayraktutan, U. (2021). The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke. Neural Regeneration Research, 16(8), 1483-1489. https://doi.org/10.4103/1673-5374.303012
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 6, 2020 |
Online Publication Date | Jan 7, 2021 |
Publication Date | Jan 7, 2021 |
Deposit Date | Jan 13, 2021 |
Publicly Available Date | Jan 13, 2021 |
Journal | Neural Regeneration Research |
Print ISSN | 1673-5374 |
Publisher | Medknow Publications |
Peer Reviewed | Peer Reviewed |
Volume | 16 |
Issue | 8 |
Pages | 1483-1489 |
DOI | https://doi.org/10.4103/1673-5374.303012 |
Keywords | antioxidants; cell-based therapy; cell-free therapy; endothelial progenitor cells; inflammatory cytokines; regenerative medicine; secretome; stroke; vasodegeneration; vasorepair |
Public URL | https://nottingham-repository.worktribe.com/output/5225135 |
Publisher URL | https://www.nrronline.org/text.asp?2021/16/8/1483/303012 |
Files
NRR secretome paper
(1.1 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-sa/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search